Chang, E <br/><br/>
Patients with melanoma metastases at cutaneous and subcutaneous sites are highly susceptible to interleukin-2-based therapy.  [electronic resource] 

 -  Journal of immunotherapy (Hagerstown, Md. : 1997)   
 - 88-90 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1524-9557 
<br/><br/><label>Standard No.: </label>10.1097/00002371-200101000-00010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Child<br/>Demography<br/>Disease Susceptibility<br/>Drug Resistance, Neoplasm<br/>Female<br/>Humans<br/>Injections, Intravenous<br/>Interleukin-2--administration & dosage<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Skin Neoplasms--drug therapy<br/>Treatment Outcome